Neural development and the ontogeny of central nervous system tumors

Neuron Glia Biology

Volumn 1, Issue 2, 2004, Pages 127-133

  Pomeroy, Scott L ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

cerebellar granule cells; cerebellum; embryonal tumors; medulloblastoma astrocy toma stem cells

Indexed keywords

EID: 34247189961     PISSN: 1740925X     EISSN: 17410533     Source Type: Journal    
DOI: 10.1017/S1740925X04000286     Document Type: Article

References (53)

1. Bachoo R.M., Maher E.A., Ligon K.L., Sharp N.E., Chan S.S., You M.J., Tang Y., De J. et al. (2002) Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 1, 269–277.
2. Bailey P. and Cushing H. (1926) A classification of the tumors of the glioma group on histogenetic basis with a correlated study of prognosis. Philadelphia: J.D. Lippincott.
3. Barker F.G. 2nd, Simmons M.L., Chang S.M., Prados M.D., Larson D.A., Sneed P.K., Wara W.M., Berger M.S. et al. (2001CATCT) EGFR overexpression and radiation response in glioblastoma multiforme. International Journal of Radiation Oncology, Biology, Physics 51, 410–418.
4. Biegel J.A., Zhou J.Y., Rorke L.B., Stenstrom C., Wainwright L.M. and Fogelgren B. (1999) Germ-line and acquired mutations of INIi in atypical teratoid and rhabdoid tumors. Cancer Research 59, 74–79.
5. Bishop J.M. (1991) Molecular themes in oncogenesis. Cell 64, 235–248.
6. Bobo R.H., Laske D.W., Akbasak A., Morrison P.F., Dedrick R.L. and Oldfield E.H. (1994) Convection-enhanced delivery of macromol-ecules in the brain. Proceedings of the National Academy of Sciences of the United States of America 91, 2076–2080.
7. Buhren J., Christoph A.H., Buslei R., Albrecht S., Wiestler O.D. and Pietsch T. (2000) Expression of the neurotrophin receptor P75NTR in medulloblastomas is correlated with distinct histological and clinical features: evidence for a medulloblastoma subtype derived from the external granule cell layer. Journal of Neuropathology and Experimental Neurology 59, 229–240.
8. Burger P.C., Pearl D.K., Aldape K., Yates A.J., Scheithauer B.W., Passe S.M., Jenkins R.B. and James C.D. (2001) Small cell architecture—a histological equivalent of EGFR amplification in glioblastoma multiforme? Journal of Neuropathology and Experimental Neurology 60, 1099–1104.
9. Cairncross J.G., Ueki K., Zlatescu M.C., Lisle D.K., Finkelstein D.M., Hammond R.R., Silver J.S., Stark P.C. et al. (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. Journal of the National Cancer Institute 90,1473-1479.
10. CBTRUS (2002) Statistical report: Primary brain tumors in the United States, 1955–1999.
11. Corcoran R.B. and Scott M.P. (2001) A mouse model for medulloblas-toma and basal cell nevus syndrome. Journal of Neurooncology 53, 307–318.
12. Dai C., Celestino J.C., Okada Y., Louis D.N., Fuller G.N. and Holland E.C. (2001) PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes and Development 15,1913-1925.
13. DeAngelis L.M. (2001) Brain tumors. New England Journal of Medicine 344,114-123.
14. Dong J., Gailani M.R., Pomeroy S.L., Reardon D. and Bale A.E. (2000) Identification of PATCHED mutations in medulloblastomas by direct sequencing. Human Mutation 16, 89–90.
15. Eberhart C.G., Kratz J.E., Schuster A., Goldthwaite P., Cohen K.J., Perlman E.J. and Burger P.C. (2002) Comparative genomic hybridiza-tion detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas. Brain Pathology 12, 36–44.
16. Farber E. (1984) The multistep nature of cancer development. Cancer Research 44, 4217–4223.
17. Fleming T.P., Matsui T., Heidaran M.A., Molloy C.J., Artrip J. and Aaronson S.A. (1992) Demonstration of an activated platelet-derived growth factor autocrine pathway and its role in human tumor cell proliferation in vitro. Oncogene 7,1355-1359.
18. Gailani M.R., Bale S.J., Leffell D.J., DiGiovanna J.J., Peck G.L., Poliak S., Drum M.A., Pastakia B. et al. (1992) Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromo-some 9. Cell 69,111-117.
19. Gilbertson R.J., Perry R.H., Kelly P.J., Pearson A.D. and Lunec J. (1997) Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. Cancer Research 57, 3272–3280.
20. Goodrich L.V., Milenkovic L., Higgins K.M. and Scott M.P. (1997) Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277,1109-1113.
21. Gould V.E. (1986) Histogenesis and differentiation: a re-evaluation of these concepts as criteria for the classification of tumors. Human Pathology 17, 212–215.
22. Grotzer M.A., Hogarty M.D., Janss A.J., Liu X., Zhao H., Eggert A., Sutton L.N., Rorke L.B. et al. (2001) MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma. Clinical Cancer Research 7, 2425–2433.
23. Hahn H., Wicking C., Zaphiropoulous P.G., Gailani M.R., Shanley S., Chidambaram A., Vorechovsky I., Holmberg E. et al. (1996) Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85, 841–851.
24. Hahn W.C., Counter C.M., Lundberg A.S., Beijersbergen R.L., Brooks M.W. and Weinberg R.A. (1999) Creation of human tumour cells with defined genetic elements. Nature 400, 464–468.
25. Hamilton S.R., Liu B., Parsons R.E., Papadopoulos N., Jen J., Powell S.M., Krush A.J., Berk T. et al. (1995) The molecular basis of Turcot's syndrome. New England Journal of Medicine 332, 839–847.
26. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B. et al. (1998) Identification of c-MYC as a target of the APC pathway. Science 281,1509-1512.
27. Hermanson M., Funa K., Hartman M., Claesson-Welsh L., Heldin C.H., Westermark B. and Nister M. (1992) Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Research 52, 3213–3219.
28. MacDonald T.J., Brown K.M., LaFleur B., Peterson K., Lawlor C., Chen Y., Packer R.J., Cogen P. et al. (2001) Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nature Genetics 29,143-152.
29. Nowell P.C. (1976) The clonal evolution of tumor cell populations. Science 194, 23–28.
30. Nowell P.C. (1986) Mechanisms of tumor progression. Cancer Research 46, 2203–2207.
31. Oliver T.G., Grasfeder L.L., Carroll A.L., Kaiser C., Gillingham C.L., Lin S.M., Wickramasinghe R., Scott M.P. et al. (2003) Transcriptional profiling of the Sonic hedgehog response: a critical role for N-myc in proliferation of neuronal precursors. Proceedings of the National Academy of Sciences of the United States of America 100, 7331–7336.
32. Packer R.J., Cogen P., Vezina G. and Rorke L.B. (1999) Medulloblastoma: clinical and biologic aspects. Neuro-oncology 1, 232–250.
33. Packer R.J., Sutton L.N., Elterman R., Lange B., Goldwein J., Nicholson H.S., Mulne L., Boyett J. et al. (1994) Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. Journal of Neurosurgery 81, 690–698.
34. Pietsch T., Waha A., Koch A., Kraus J., Albrecht S., Tonn J., Sorensen N., Berthold F. etal. (1997) Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. Cancer Research 57, 2085–2088.
35. Pomeroy S.L., Tamayo P., Gaasenbeek M., Sturla L.M., Angelo M., McLaughlin M.E., Kim J.Y., Goumnerova L.C. et al. (2002) Predic-tion of central nervous system embryonal tumour outcome based on gene expression. Nature 415, 436–442.
36. Reardon D.A., Jenkins J.J., Sublett J.E., Burger P.C. and Kun L.K. (2000) Multiple genomic alterations including N-myc amplification in a primary large cell medulloblastoma. Pediatric Neurosurgery 32,187-191.
37. Rorke L.B. (1983) The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors. Journal of Neuropathology and Experimental Neurology 42,1-15.
38. Rubin J.B. and Rowitch D.H. (2002) Medulloblastoma: a problem of developmental biology. Cancer Cell 2, 7–8.
39. Segal R.A., Goumnerova L.C., Kwon Y.K., Stiles C.D. and Pomeroy S.L. (1994) Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proceedings of the National Academy of Sciences of the United States of America 91, 12867-12871.
40. Shamah S.M., Stiles C.D. and Guha A. (1993) Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells. Molecular and Cellular Biology 13,7203-7212.
41. Sidransky D., Mikkelsen T., Schwechheimer K., Rosenblum M.L., Cavanee W. and Vogelstein B. (1992) Clonal expansion of P53 mutant cells is associated with brain tumour progression. Nature 355, 846–847.
42. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J. and Dirks P.B. (2003) Identification of a cancer stem cell in human brain tumors. Cancer Research 63, 5821–5828.
43. Smith J.S., Perry A., Borell T.J., Lee H.K., O'Fallon J., Hosek S.M., Kimmel D., Yates A. et al. (2000) Alterations of chromosome arms ip and i9q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. Journal of Clinical Oncology 18, 636–645.
44. Steck P.A., Pershouse M.A., Jasser S.A., Yung W.K., Lin H., Ligon A.H., Langford L.A., Baumgard M.L. et al. (1997) Identification of a candidate tumour suppressor gene, MMACi, at chromosome 10423.3 that is mutated in multiple advanced cancers. Nature Genetics 15,356-362.
45. Taipale J., Chen J.K., Cooper M.K., Wang B., Mann R.K., Milenkovic L., Scott M.P. and Beachy P.A. (2000) Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 406, 1005–1009.
46. Taylor M.D., Liu L., Raffel C., Hui C.C., Mainprize T.G., Zhang X., Agatep R., Chiappa S. et al. (2002) Mutations in SUFU predispose to medulloblastoma. Nature Genetics 31,306-310.
47. Wechsler-Reya R.J. and Scott M.P. (1999) Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog. Neuron 22,103-114.
48. Wechsler-Reya R. and Scott M.P. (2001) The developmental biology of brain tumors. Annual Review of Neuroscience 24,385-428.
49. Weinberg R.A. (1989) Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Research 49,3713-3721.
50. Williams R.W. and Herrup K. (1988) The control of neuron number. Annual Review of Neuroscience 11, 423–453.
51. Yokota N., Aruga J., Takai S., Yamada K., Hamazaki M., Iwase T., Sugimura H. and Mikoshiba K. (1996) Predominant expression of human zic in cerebellar granule cell lineage and medulloblastoma. Cancer Research 56,377-383.
52. Zurawel R.H., Chiappa S.A., Allen C. and Raffel C. (1998) Sporadic medulloblastomas contain oncogenic beta-catenin mutations. Cancer Research 58, 896–899.
53. Zurawel R.H., Allen C., Chiappa S., Cato W., Biegel J., Cogen P., de Sauvage F. and Raffel C. (2000) Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma. Genes Chromosomes Cancer 27, 44–51.